ProfileGDS4284 / 1569874_s_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 2% 7% 2% 3% 26% 2% 6% 12% 1% 34% 4% 5% 5% 23% 7% 3% 1% 4% 34% 7% 5% 1% 12% 5% 10% 25% 1% 23% 32% 2% 24% 2% 30% 1% 0% 1% 9% 1% 27% 2% 26% 20% 21% 25% 18% 1% 6% 26% 2% 5% 23% 1% 5% 7% 29% 5% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control4.571392
GSM687648Patient 402 control11.16687
GSM687653Patient 403 control5.601792
GSM687658Patient 404 control7.839263
GSM687663Patient 411 control70.664626
GSM687668Patient 422 control6.206622
GSM687673Patient 424 control12.66866
GSM687678Patient 425 control21.408412
GSM687683Patient 427 control5.27581
GSM687688Patient 428 control100.27134
GSM687695Patient 441 control18.35194
GSM687699Patient 443 control12.71635
GSM687704Patient 444 control10.24265
GSM687707Patient 448 control61.422323
GSM687712Patient 449 control13.01647
GSM687719Patient 450 control8.539253
GSM687724Patient 451 control5.244091
GSM687728Patient 452 control9.952984
GSM687646Patient 401 treated 24h99.737234
GSM687649Patient 402 treated 24h10.99697
GSM687665Patient 411 treated 24h10.59295
GSM687651Patient 402 treated 4 weeks3.482791
GSM687667Patient 411 treated 4 weeks22.589812
GSM687670Patient 422 treated 24h11.315
GSM687671Patient 422 treated 4 weeks16.271810
GSM687654Patient 403 treated 24h51.104725
GSM687675Patient 424 treated 24h3.672841
GSM687685Patient 427 treated 24h48.721323
GSM687656Patient 403 treated 4 weeks77.417832
GSM687677Patient 424 treated 4 weeks5.693882
GSM687687Patient 427 treated 4 weeks49.284124
GSM687692Patient 428 treated 4h6.441272
GSM687716Patient 449 treated 4h80.005330
GSM687722Patient 450 treated 4h5.117151
GSM687680Patient 425 treated 24h2.035190
GSM687690Patient 428 treated 24h4.088341
GSM687700Patient 443 treated 24h28.13489
GSM687705Patient 444 treated 24h4.449321
GSM687714Patient 449 treated 24h59.165727
GSM687721Patient 450 treated 24h7.108742
GSM687682Patient 425 treated 4 weeks58.811826
GSM687694Patient 428 treated 4 weeks35.568520
GSM687702Patient 443 treated 4 weeks47.338821
GSM687718Patient 449 treated 4 weeks62.67525
GSM687723Patient 450 treated 4 weeks35.930318
GSM687661Patient 404 treated 4h4.596431
GSM687710Patient 448 treated 4h11.15986
GSM687726Patient 451 treated 4h69.323726
GSM687730Patient 452 treated 4h18.02622
GSM687660Patient 404 treated 24h15.48755
GSM687697Patient 441 treated 24h68.790823
GSM687709Patient 448 treated 24h2.93711
GSM687725Patient 451 treated 24h13.8545
GSM687729Patient 452 treated 24h20.47017
GSM687727Patient 451 treated 4 weeks91.770229
GSM687731Patient 452 treated 4 weeks11.75985